$2.35 0.04 (+1.73%)
11/25/2009 11:48 AM

Keryx Biopharmaceuticals (KERX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Featured Broker Partners